What are the steps to conduct a medical research paper?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Conduct a Medical Research Paper

The foundation of any successful medical research paper begins with developing a clear, focused research question using the PICO framework (Population, Intervention, Comparator, Outcome), followed by a rigorous protocol that serves as your roadmap through study design, data collection, analysis, and dissemination. 1

Phase 1: Formulating the Research Question

Apply the FINER Criteria

Your research question must be Feasible, Interesting, Novel, Ethical, and Relevant (FINER) to ensure it generates clinically impactful knowledge. 1, 2 This prevents wasting resources on questions of marginal interest or those that ignore important existing work. 1

Structure Using PICO Framework

  • Population: Define your target patient population with specific characteristics 1, 3
  • Intervention/Exposure: Specify the intervention or exposure being studied 1, 3
  • Comparator: Identify what you're comparing against (control, standard care, placebo) 1, 3
  • Outcome: Define outcome measures as precisely as if conducting an original study yourself 1
  • Timeframe: Establish the duration reasonable for outcome development 1

Conduct Comprehensive Literature Review

Perform an extensive literature search to understand what is already known, identify gaps in current evidence, and justify why a new study is needed. 1 Search ClinicalTrials.gov to avoid unnecessary duplication and learn from similar ongoing studies. 1

Phase 2: Protocol Development

Create a Detailed Written Protocol

A well-developed protocol is the single most critical determinant of overall study quality and potential bias. 1, 3 The protocol serves as your complete roadmap and should include: 1, 3

  • Study rationale and objectives: Classify as descriptive and/or analytical 3
  • Study design: Clearly identify whether RCT, prospective cohort, case-control, cross-sectional, or case series 1
  • Eligibility criteria: Detailed inclusion/exclusion criteria 3
  • Sample size calculation: Pre-planned with power calculations 3
  • Data collection methods: Specify timing and assessment methods for all variables 3
  • Statistical analysis plan: Include pre-planned strategies to identify and mitigate bias 3

Register Your Protocol

Register the protocol prospectively in ClinicalTrials.gov or appropriate registry before patient enrollment or data collection begins. 1, 3 This prevents selective publication, protocol changes, and unnecessary research duplication. 1

Adhere to Reporting Standards

Follow established guidelines: 3

  • PRISMA-P for systematic reviews and meta-analyses 1
  • SPIRIT for clinical trial protocols 3
  • ARRIVE for animal research 3

Phase 3: Study Design Selection

Match Design to Question

The study design must be appropriate for the specific question being asked. 1 Consider this hierarchy: 1

  • Randomized Controlled Trials (RCTs): Provide maximum-quality evidence on benefits and risks of interventions; use when sufficient preliminary data exists 1
  • Prospective Cohort Studies: Preferred for higher-level evidence when RCTs are not feasible 1, 3
  • Registries: Essential for assessing real-world use, costs, and effectiveness 1
  • Observational Studies: Appropriate when generating hypotheses or preparing ground for RCTs 1

Common Pitfall to Avoid

Do not combine results from observational cohorts and randomized trials in the same analysis, as differences in study design, follow-up duration, and exposure definitions lead to misleading findings. 1

Phase 4: Data Collection and Management

Define All Variables Precisely

Provide a complete list of core variables grouped as: 3

  • Baseline characteristics
  • Exposures
  • Outcomes (primary and secondary, pre-specified before analysis) 3

Describe each variable in detail including timing of collection and assessment methods. 3

Ensure Reproducibility

Test and report: 1

  • Observer reproducibility: Inter-observer and intra-observer variability
  • Test-retest reproducibility: Using intra-class correlation coefficients (ICC) with 95% CI and Bland-Altman analysis as minimum standards 1
  • Never use simple correlations or mean value comparisons for reporting reproducibility 1

Enroll Consecutively

Begin enrolling consecutive patients at study onset to avoid selection bias. 3 Document recruitment strategies to understand potential biases in your target sample. 3

Phase 5: Statistical Analysis

Pre-Specify Analysis Plan

The statistical analysis plan must be developed during protocol creation, not after data collection. 3 Include: 1

  • For prognostic studies: Univariable and multivariable analysis (logistic or Cox regression) adjusted for traditional risk factors 1
  • For prediction models: Assess discrimination (ROC curve, sensitivity, specificity), calibration (calibration slopes, Hosmer-Lemeshow test), and additional predictive value (C-statistic increment, NRI, IDI) 1
  • For heterogeneity assessment: Use I² and Cochran Q statistics with forest plots for visual inspection 1

Collaborate with Statisticians

Engage expert statisticians early for sample size estimation and analysis planning. 1 This collaboration is essential for avoiding fatal methodological flaws. 1

Phase 6: Quality Assessment and Bias Mitigation

Assess Study Quality

Use established tools to assess potential for bias: 1

  • Risk of bias assessment tools for included studies
  • GRADE or similar frameworks for certainty of evidence 1

Address Ethical Considerations

Obtain appropriate institutional review board or ethics committee approval before study initiation. 3 Include trial registration numbers in all publications. 3

Phase 7: Dissemination

Plan Multi-Directional Dissemination

  • Identify target audiences (specialists, clinicians, patients, stakeholders) 1
  • Use multiple venues while respecting policies on data reuse 1
  • Encourage collaborator participation to amplify dissemination 1

Report Completely and Transparently

Follow reporting guidelines specific to your study design to ensure concise, explicit, and complete reporting. 4 Both positive and negative findings should be published to advance the field. 1

Critical Success Factors

The three most common reasons research fails are: 1

  1. Poorly defined research question leading to inappropriate study inclusion and substantial heterogeneity 1
  2. Vague protocol criteria introducing unnecessary subjectivity during screening and data extraction 1
  3. Inadequate subject matter expertise in translating the hypothesis into an executable protocol 1

Avoid these pitfalls by investing substantial time upfront in question formulation and protocol development before collecting any data. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Designing High-Quality Prospective Studies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.